Mayo Clinic 2bPrecise Partner to Develop Genomics-Based Clinical Decision Support Tools

Shared by Radhika Narayanan | 2 10 4 | about 2 years ago

Mayo Clinic, 2bPrecise Partner to Develop Genomics-Based Clinical Decision Support Tools

As genomics begins to play a greater role in healthcare thanks to precision medicine initiatives and the advancement of science 2bPrecise LLC an EHR-agnostic cloud-based precision medicine platform today announced a technology license agreement with Mayo Clinic as well as a collaboration to develop and research genomics-based care protocols As part of the licensing agreement Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care education and researchMayo Clinic chose 2bPrecise as a genetic research partner based on the companys robust clinical-genomic platform and the two organizations will begin their collaboration by incorporating Mayo Clinics clinical protocols into 2bPrecises platform to derive insights from combined clinical and genomic research data to improve care for patients with cardiovascular genetic disease such as familial hypercholesterolemiaThe 2bPrecise platform harmonizes clinical and genomic information to extract patient-specific insights and present them in an actionable way to the clinician within their current EHR workflow overlaying knowledge sources to guide and enable clinical genomics at point of careMayo Clinic has a very robust genomics research discipline says Assaf Halevy founder and CEO of 2bPrecise The wealth of both genetic research and clinical data within the clinic is staggering This is why we are so excited to collaborate with premier organizations like Mayo Clinic to advance genomic science and help make it clinically actionable

Read More On hitconsultant.net

Categories Digital Biology & Genetics



Places mentioned in this article

Organizations mentioned in this article

0 Votes

You must log in to post a comment